Log in to save to my catalogue

Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with f...

Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with f...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2645ed61e5a340d0ae5c26e917c003c3

Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patients with pancreatic cancer: results from the NAPOLEON-2 study (NN-2302)

About this item

Full title

Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patients with pancreatic cancer: results from the NAPOLEON-2 study (NN-2302)

Publisher

England: SAGE Publishing

Journal title

Therapeutic advances in medical oncology, 2025-01, Vol.17, p.17588359251320768

Language

English

Formats

Publication information

Publisher

England: SAGE Publishing

More information

Scope and Contents

Contents

Relationships between cancer onset, progression, and inflammation have been reported; yet, the significance of inflammatory markers before and after treatment with nanoliposomal irinotecan and fluorouracil with folic acid (NFF) is unclear.
We aimed to (1) investigate whether worsening inflammation is associated with disease progression and wheth...

Alternative Titles

Full title

Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patients with pancreatic cancer: results from the NAPOLEON-2 study (NN-2302)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2645ed61e5a340d0ae5c26e917c003c3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2645ed61e5a340d0ae5c26e917c003c3

Other Identifiers

ISSN

1758-8340,1758-8359

E-ISSN

1758-8359

DOI

10.1177/17588359251320768

How to access this item